IMU 1.89% 5.4¢ imugene limited

Ann: Imugene PD1-Vaxx Immunotherapy Patent Granted in the US, page-29

  1. 290 Posts.
    lightbulb Created with Sketch. 49
    I see an upside to keeping the price low for now, allows me to keep topping up regularly knowing where the share price could be at this time next year. This is a long term hold with a huge upside IMO. Also great to see their partnership with ALA is progressing to the next stage
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.